Brahmi Vati
Brahmi Vati is a classical Ayurvedic vati, a herbal tablet or pill. Listed in Ayurvedic Formulary of India (AFI) Part II, entry 16:45. The Ayurvedic Formulary of India (Part II, entry 16:45) lists 38 ingredients, beginning with Abhraka bhasma, Sangeyasaba bhasma, Akika bhasma and Manikya bhasma.
| Also known as | Brahmi Vati, BrahmiVati |
|---|---|
| Pharmacopoeia status | Listed in Ayurvedic Formulary of India (AFI) Part II, entry 16:45; Brahmi (Bacopa monnieri) individually monographed in Ayurvedic Pharmacopoeia of India (API) Part I, Indian Pharmacopoeia, and referenced in WHO monographs; StatPearls (NCBI) comprehensive monograph available; the gold variant classified under Schedule E(1) controlled formulations |
Composition
As given in the Ayurvedic Formulary of India, Part II, entry 16:45 (BRAHMI VATI), which cites Siddhayogasangraha, Vatarogadhikara. Names, parts and quantities are transcribed as printed and checked row by row against the book. Manufacturers' versions of a classical formulation can differ from the formulary.
| # | Ingredient | Part | Quantity |
|---|---|---|---|
| 1 | Abhraka bhasma * | 6 g. | |
| 2 | Sangeyasaba bhasma (pisti) * | 6 g. | |
| 3 | Akika bhasma (pisti) * | 6 g. | |
| 4 | Manikya bhasma (pisti) | 6 g. | |
| 5 | Candrodaya | 6 g. | |
| 6 | Pravala bhasma (pisti) | 6 g. | |
| 7 | Kaharuba pisti (pisti) * | 6 g. | |
| 8 | Svarna bhasma | 6 g. | |
| 9 | Mukta bhasma (pisti) | 6g. | |
| 10 | Jayaphala (jatiphala) | seed | 4g. |
| 11 | Lavanga | flower | 4 g. |
| 12 | Katha (kustha) | root | 4 g. |
| 13 | Jatipatri | Ar. | 4 g. |
| 14 | Krsnajiraka | fruit | 4g. |
| 15 | Pippali | fruit | 4 g. |
| 16 | Tvak | stem bark | 4 g. |
| 17 | Anistna | fruit | 4 g. |
| 18 | Asagandha (asvagandha) | root | 4 g. |
| 19 | Akarakara (Akarakarabha) | root | 4 g. |
| 20 | Dhanyaka | fruit | 4 g. |
| 21 | Vansalocana (VamSa) | s.c. | 4 g. |
| 22 | Ela (Saksmala) | seed | 4 g. |
| 23 | Sankhapuspi | PI; | 4 g. |
| 24 | Sveta candana | heart wood | 4g. |
| 25 | Surpha (misreya) * | fruit | illegible |
| 26 | Patra (tvakpatra) | leaf | 4g. |
| 27 | NagakeSara | Adr. | 4 g. |
| 28 | Ritmimastagi | exudate | 4g. |
| 29 | Pippalamdla (pippali) | root | 4g. |
| 30 | Citraka | root | 4 g. |
| 31 | Kulinjana | rhizome | 4 g. |
| 32 | Kastdri (mrgamada) | 18 g. | |
| 33 | Ambar | 18 g. | |
| 34 | Brahmi | PI. | 18 g. |
| 35 | Nisotha (Trivrt) | root | 18 g. |
| 36 | Agara (Aguru) * | heart wood | illegible |
| 37 | Kumkuma | Stg. | 18 g. |
| 38 | Brahmi svarasa | whole plant | Q.S. |
Cells marked illegible are damaged in the source scan. The ingredient name is shown where it was readable, and nothing is inferred to fill a gap.
* The scanned text was damaged at this row and the name was read from the entry's own Sanskrit verse.
The Formulary gives the dose as 125 to 250 mg. This is what the Formulary records for the classical preparation. It is not a dose for any product, and not advice to take anything.
The evidence at a glance
10papers on this site for this drug, published 2013 to 2024, every one with a DOI.
- 2Other clinical studies and reviews
- 8Laboratory and animal studies
A count is not a conclusion and a tier is a study design, not a verdict. Everything listed here is laboratory or animal work, which does not show an effect in people. Each paper is listed with what it measured on the page below. See the research index for how papers are tiered.
Names and identification
| Language | Name |
|---|---|
| English | Brahmi Vati |
Where is it described in the classical texts?
Rasaratna Samuchchaya (16th century); also described in Bhaishajya Ratnavali (Unmada/Apasmara Chikitsa) and Rasa Tarangini; the Suvarna (gold) variant is described in later Rasa Shastra texts. The Ayurvedic Formulary of India instead attributes the formula to Siddhayogasangraha, Vatarogadhikara.
How does it work?
- Synaptic repair and neuronal synthesis: Bacosides A and B enhance nerve impulse transmission and promote repair of damaged neurons by upregulating neuronal synthesis, kinase activity, and restoring synaptic function
- Neurotransmitter modulation: Bacopa influences synthesis and availability of serotonin (5-HT), acetylcholine, dopamine, and GABA, maintaining neurotransmitter balance critical for memory and mood
- Neuroprotective antioxidant: Increases concentration of GSH and enzymatic antioxidants (SOD, CAT, GPx) and acts as free radical scavenging agent, protecting neurons from oxidative damage
- Cholinergic enhancement: Reported to inhibit acetylcholinesterase activity, increasing acetylcholine availability at synapses
- Anti-anxiety (Medhya Rasayana): Reported to modulate GABAergic and serotonergic pathways
Which traditional uses are supported by research?
These summaries come from the source notes, which do not name the studies behind them.
- Memory and cognition (Medhya Rasayana): traditionally used to support memory and cognition. Clinical studies and a meta-analysis have reported improvements in verbal learning, delayed recall, and memory acquisition.
- Anxiety and stress: traditionally used for anxiety and stress. Clinical studies have reported modulation of serotonergic and GABAergic pathways.
- Alzheimer’s disease: traditionally used as supportive care. Studies have reported cholinergic and neuroprotective activity.
- Epilepsy and convulsions (Apasmara): traditionally used for epilepsy and convulsions. Studies have reported anticonvulsant potential linked to GABA modulation.
What do recent studies show?
- Chaudhari KS, Tiwari NR, Tiwari RR and others 2017. Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer’s Disease. Annals of neurosciences. PMID 28588366 · doi:10.1159/000475900
Bacosides enhance nerve impulse transmission, promote repair of damaged neurons by upregulating neuronal synthesis and kinase activity, and restore synaptic function. - Stough C, Singh H, Zangara A 2015. Mechanisms, Efficacy, and Safety of Bacopa monnieri (Brahmi) for Cognitive and Brain Enhancement. Evidence-based complementary and alternative medicine : eCAM. PMID 26413128 · doi:10.1155/2015/717605
Evidence-based review confirmed Brahmi’s pharmacological effects including memory boosting in Alzheimer’s Disease, antiparkinson, antistroke, and anticonvulsant potentials through multiple neurotransmitter pathway modulation. - Mathur D, Goyal K, Koul V and others 2016. The Molecular Links of Re-Emerging Therapy: A Review of Evidence of Brahmi (Bacopa monniera). Frontiers in pharmacology. PMID 26973531 · doi:10.3389/fphar.2016.00044
Comprehensive molecular analysis identified bacosides, brahmine, herpestine, and flavonoids as key active compounds mediating neuroprotective, antioxidant, and anti-inflammatory mechanisms.
Only studies that could be traced to a published paper are listed here. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.
Recent safety updates
- Brahmi (Bacopa) alone has high therapeutic index and is generally well tolerated; most common side effects are GI (increased stool frequency, nausea, abdominal cramps); however, Brahmi Vati contains Rasasindura (mercury compound) and potentially Suvarna Bhasma requiring strict physician supervision
- Always check heavy metal compliance certificates when purchasing; contraindicated in pregnancy and lactation; the gold-containing variant (Suvarna Brahmi Vati) is costlier and more potent - requires even stricter medical oversight; not for long-term unsupervised use due to mineral content
Dosage forms and preparation
Dosage Forms: Vati (tablet/pill), Modern compressed tablet, Capsule (modern)
Standard Dosage: 125-250 mg twice daily with milk or water, as given in the Ayurvedic Formulary of India, Part II, entry 16:45. The formulary attributes this formula to Siddhayogasangraha, Vatarogadhikara.
Optimal Timing: Morning and before bedtime, preferably with milk for Medhya (cognitive) effect
Storage: Store in airtight containers in a cool, dry place. Protect from moisture and light. Temperature not exceeding 30°C.
Marker Compounds: Bacoside A, Reserpine (from Sarpagandha), Ajmalicine, Beta-asarone (from Vacha), Jatamansone (from Jatamansi), Piperine
Vehicle (Anupana): Warm milk, honey, or ghee
Synergistic Combinations
- Brahmi Ghritam
- Saraswatarishta
- Ashwagandha Churna
- Shankhapushpi Syrup
- Jatamansi Churna
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Other clinical studies and reviews2
- 2017. Neurocognitive Effect of Nootropic Drug Brahmi (Bacopa monnieri) in Alzheimer's DiseaseAnnals of neurosciences. PMID 28588366 · doi:10.1159/000475900
- 2016. The Molecular Links of Re-Emerging Therapy: A Review of Evidence of Brahmi (Bacopa monniera)Frontiers in pharmacology. PMID 26973531 · doi:10.3389/fphar.2016.00044
Laboratory and animal studies8
- 2015. Mechanisms, Efficacy, and Safety of Bacopa monnieri (Brahmi) for Cognitive and Brain EnhancementEvidence-based complementary and alternative medicine : eCAM. PMID 26413128 · doi:10.1155/2015/717605
- 2024. Efficacy of Brahmi vati and Aswagandharista in major depressive disorder: A randomized controlled trialJournal of Ayurveda and integrative medicine. PMID 39631219 · doi:10.1016/j.jaim.2024.101022
- 2024. Efficacy of ayurveda medications, Brahmi vati and Saraswatarista, in generalized anxiety disorder- a randomized controlled trialJournal of Ayurveda and integrative medicine. PMID 39626587 · doi:10.1016/j.jaim.2024.101033
- 2013. HPLC analysis and standardization of Brahmi vati - An Ayurvedic poly-herbal formulationJournal of young pharmacists : JYP. PMID 24396246 · doi:10.1016/j.jyp.2013.09.001
- 2019. Effect of Brahmi vati and Sarpagandha Ghana vati in management of essential hypertension - A randomized, double blind, clinical studyJournal of Ayurveda and integrative medicine. PMID 29242090 · doi:10.1016/j.jaim.2017.04.001
- 2013. Standardization of a traditional polyherbo-mineral formulation - Brahmi vatiAfrican journal of traditional, complementary, and alternative medicines : AJTCAM. PMID 24146464 · doi:10.4314/ajtcam.v10i3.1
- 2022. Efficacy of Brahmi vati in generalised anxiety disorder - Randomized double blind comparative clinical trialJournal of Ayurveda and integrative medicine. PMID 35325682 · doi:10.1016/j.jaim.2022.100552
- 2018. Effect of traditional medicine brahmi vati and bacoside A-rich fraction of Bacopa monnieri on acute pentylenetetrzole-induced seizures, amphetamine-induced model of schizophrenia, and scopolamine-induced memory loss in laboratory animalsEpilepsy & behavior : E&B. PMID 29414544 · doi:10.1016/j.yebeh.2017.12.040
Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.
Available from Age Ayurveda
This encyclopedia is published by Age Ayurveda. The products below are ours, and are listed here because they contain or use what this page describes.
ADHD EaseHerbs traditionally used to support mental clarity, calm and attention.Ask about this on WhatsApp
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.